Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 22 minutes agoBioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 4 days agoStarting Monday, the elderly and those with weakened immune systems will be able to get a shot free...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 1 day agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 19 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 2 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
mRNA Therapeutics Market is Estimated to be USD 45.85 billion by 2031; Driven by Innovative...
Digital Journal· 6 days agoAccording to SNS Insider, the mRNA Therapeutics market will be reaching USD 45.85 billion by 2031 and will be growing at a CAGR of 1.7% over the forecast period of 2024-2031. mRNA Therapeutics Market Market Scope The messenger ribonucleic acid (mRNA